Leverage advanced AI and expert medical review to forecast clinical trial outcomes with unprecedented accuracy. Make data-driven investment decisions in pharmaceutical innovation.
Powered By
Watch how our platform can give you a detailed scientific clinical trial due diligence with clear Possiblity of Success (PoS), backed by expert medical review, within 72 hours.
Our proprietary AI engine combines multiple data sources to deliver comprehensive trial intelligence.
We automatically gather data from ClinicalTrials.gov, PubMed, FDA databases, and proprietary sources to build a comprehensive trial profile.
Our biomedical LLM analyzes trial design, endpoints, patient populations, and historical data to predict success probability with above 73% accuracy and still improving.
Medical experts validate AI predictions and provide nuanced insights on safety concerns, regulatory risks, and competitive landscape.
Join leading institutional investors and pharmaceutical companies using AI to make smarter decisions.
Get Started